SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000895345-23-000601
Filing Date
2023-11-03
Accepted
2023-11-03 16:30:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 ff2670875_13da4-aileron.htm SC 13D/A 60050
  Complete submission text file 0000895345-23-000601.txt   61356
Mailing Address C/O SATTER INVESTMENT MANAGEMENT, LLC 676 NORTH MICHIGAN AVENUE, SUITE 4000 CHICAGO IL 60611
Business Address
Satter Muneer A (Filed by) CIK: 0001315797 (see all company filings)

Type: SC 13D/A

Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Subject) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90032 | Film No.: 231376817
SIC: 2834 Pharmaceutical Preparations